Rolph Timothy, the Chief Scientific Officer of Akero Therapeutics Inc . (NASDAQ:AKRO), recently executed a notable share sale, as per the latest SEC filing. The timing is particularly interesting as ...

In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa, who has ...

The S&P 500 SPX closed down 0.9% on Friday, leaving the U.S. large-cap stock index with a loss this week of 0.2%, according to Dow Jones Market Data. The S&P 500 snapped a three-day winning streak and ...

Meanwhile, the rectangular channel between $2,817 and $2,150 could prove crucial as ETH moved range-bound in this zone ...

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

Is BigBear.ai the next Palantir? On Thursday, BigBear.ai said the Department of Defense awarded it a contract to advance its Virtual Anticipation Network (VANE) prototype. Defense is just one of the ...

A mid-January note from Mitra Azizirad, Microsoft's chief operating officer of strategic mission and technologies, also ...

From thinking investing is like gambling to believing that cash is safer than stocks, these are some of the most persistent ...

Arhaus, Inc. (NASDAQ:ARHS) is an omni-channel retailer and lifestyle brand that sells premium home furnishings. It has around ...

BofA Global Research analyst Justin Post reiterated a buy rating on Expedia and lifted his price target on the stock to $250 a share from $221 a share. BofA continues to favor the stock over other ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

“The rate cut, coupled with recent liquidity-boosting measures, is expected to drive fresh investments and kick-start the consumption cycle. Sectors such as banking, auto, FMCG, consumer durables, ...